IgG avidity to Pseudomonas aeruginosa over the course of chronic lung biofilm infection in cystic fibrosis
- PMID: 29032178
- DOI: 10.1016/j.jcf.2017.09.004
IgG avidity to Pseudomonas aeruginosa over the course of chronic lung biofilm infection in cystic fibrosis
Abstract
Background and objectives: The mechanisms leading to low effectiveness of the humoral immune response against P. aeruginosa in cystic fibrosis (CF) are poorly understood. The aim of the present study was to assess the avidity maturation of specific antipseudomonal IgG before and during the development of chronic lung infection in a cohort of Danish CF patients.
Methods: Avidity maturation was assessed against a pooled P. aeruginosa antigen (St-Ag) and against P. aeruginosa alginate in 10 CF patients who developed chronic lung infection and 10 patients who developed intermittent lung colonization, using an ELISA technique with the thiocyanate elution method. Avidity was quantitatively determined by calculating the avidity Constant (Kav).
Results: IgG avidity to St-Ag significantly increased at the onset (Median Kav=2.47) and one year after the onset of chronic infection (Median Kav=3.27), but did not significantly changed in patients who developed intermittent colonization. IgG avidity against alginate did not significantly change over the years neither in patients who developed chronic lung infection (Median Kav=3.84 at the onset of chronic infection), nor in patients who developed intermittent colonization.
Conclusion: IgG avidity to P. aeruginosa alginate does not significantly enhance as chronic lung infection progresses. This probably plays a role in the difficulty to mount an effective opsonophagocytic killing to clear mucoid P. aeruginosa infection in CF.
Keywords: Biofilm; Chronic infection; Cystic fibrosis; Humoral response; IgG avidity; Pseudomonas aeruginosa.
Copyright © 2017. Published by Elsevier B.V.
Similar articles
-
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.APMIS Suppl. 2003;(116):1-47. APMIS Suppl. 2003. PMID: 14692154 Review.
-
Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.J Immunol. 1995 Aug 15;155(4):2029-38. J Immunol. 1995. PMID: 7636254
-
Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry.Thorax. 1996 Jul;51(7):733-8. doi: 10.1136/thx.51.7.733. Thorax. 1996. PMID: 8882082 Free PMC article.
-
Secretory IgA response against Pseudomonas aeruginosa in the upper airways and the link with chronic lung infection in cystic fibrosis.Pathog Dis. 2017 Aug 31;75(6). doi: 10.1093/femspd/ftx069. Pathog Dis. 2017. PMID: 28645157
-
Mechanisms of humoral immune response against Pseudomonas aeruginosa biofilm infection in cystic fibrosis.J Cyst Fibros. 2018 Mar;17(2):143-152. doi: 10.1016/j.jcf.2017.08.012. Epub 2017 Oct 21. J Cyst Fibros. 2018. PMID: 29033275 Review.
Cited by
-
Chitosan-Based Functional Films Integrated with Magnolol: Characterization, Antioxidant and Antimicrobial Activity and Pork Preservation.Int J Mol Sci. 2021 Jul 21;22(15):7769. doi: 10.3390/ijms22157769. Int J Mol Sci. 2021. PMID: 34360535 Free PMC article.
-
Pseudomonas aeruginosa infection induces intragraft lymphocytotoxicity that triggers lung transplant antibody-mediated rejection.Sci Transl Med. 2025 Feb 5;17(784):eadp1349. doi: 10.1126/scitranslmed.adp1349. Epub 2025 Feb 5. Sci Transl Med. 2025. PMID: 39908350 Free PMC article.
-
Chronic biofilm-based infections: skewing of the immune response.Pathog Dis. 2018 Apr 1;76(3):fty023. doi: 10.1093/femspd/fty023. Pathog Dis. 2018. PMID: 29718176 Free PMC article. Review.
-
Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response.Front Immunol. 2024 Jun 28;15:1405376. doi: 10.3389/fimmu.2024.1405376. eCollection 2024. Front Immunol. 2024. PMID: 39015565 Free PMC article. Review.
-
Understanding Pseudomonas aeruginosa-Host Interactions: The Ongoing Quest for an Efficacious Vaccine.Cells. 2020 Dec 5;9(12):2617. doi: 10.3390/cells9122617. Cells. 2020. PMID: 33291484 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
